208 related articles for article (PubMed ID: 1676673)
1. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
Peles E; Levy RB; Or E; Ullrich A; Yarden Y
EMBO J; 1991 Aug; 10(8):2077-86. PubMed ID: 1676673
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells.
Jallal B; Schlessinger J; Ullrich A
J Biol Chem; 1992 Mar; 267(7):4357-63. PubMed ID: 1347042
[TBL] [Abstract][Full Text] [Related]
3. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.
Peles E; Lamprecht R; Ben-Levy R; Tzahar E; Yarden Y
J Biol Chem; 1992 Jun; 267(17):12266-74. PubMed ID: 1351056
[TBL] [Abstract][Full Text] [Related]
4. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor stimulates the tyrosine phosphorylation of a 38-kDa protein that specifically associates with the src homology domain of phospholipase C-gamma 1.
Ohmichi M; Decker SJ; Saltiel AR
J Biol Chem; 1992 Oct; 267(30):21601-6. PubMed ID: 1400471
[TBL] [Abstract][Full Text] [Related]
6. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
[TBL] [Abstract][Full Text] [Related]
8. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.
Reith AD; Ellis C; Lyman SD; Anderson DM; Williams DE; Bernstein A; Pawson T
EMBO J; 1991 Sep; 10(9):2451-9. PubMed ID: 1714377
[TBL] [Abstract][Full Text] [Related]
10. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
11. Activation of phospholipase C gamma in Schizosaccharomyces pombe by coexpression of receptor or nonreceptor tyrosine kinases.
Arkinstall S; Payton M; Maundrell K
Mol Cell Biol; 1995 Mar; 15(3):1431-8. PubMed ID: 7862136
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-gamma 1 by a kinase activity associated with the product of the trk protooncogene.
Vetter ML; Martin-Zanca D; Parada LF; Bishop JM; Kaplan DR
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5650-4. PubMed ID: 1712104
[TBL] [Abstract][Full Text] [Related]
13. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.
Fazioli F; Kim UH; Rhee SG; Molloy CJ; Segatto O; Di Fiore PP
Mol Cell Biol; 1991 Apr; 11(4):2040-8. PubMed ID: 1672440
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
Spivak-Kroizman T; Rotin D; Pinchasi D; Ullrich A; Schlessinger J; Lax I
J Biol Chem; 1992 Apr; 267(12):8056-63. PubMed ID: 1349015
[TBL] [Abstract][Full Text] [Related]
15. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.
Zeng L; Sachdev P; Yan L; Chan JL; Trenkle T; McClelland M; Welsh J; Wang LH
Mol Cell Biol; 2000 Dec; 20(24):9212-24. PubMed ID: 11094073
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine 785 is a major determinant of Trk--substrate interaction.
Obermeier A; Halfter H; Wiesmüller KH; Jung G; Schlessinger J; Ullrich A
EMBO J; 1993 Mar; 12(3):933-41. PubMed ID: 8384556
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor induces the tyrosine phosphorylation and activation of phospholipase C-gamma 1, Fyn and Lyn kinases, and phosphatidylinositol 3-kinase in a human B cell line.
Kuruvilla A; Pielop C; Shearer WT
J Immunol; 1994 Dec; 153(12):5433-42. PubMed ID: 7989748
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signaling complex.
Morrison DK; Kaplan DR; Rhee SG; Williams LT
Mol Cell Biol; 1990 May; 10(5):2359-66. PubMed ID: 1691440
[TBL] [Abstract][Full Text] [Related]
19. Mapping of sites on the Src family protein tyrosine kinases p55blk, p59fyn, and p56lyn which interact with the effector molecules phospholipase C-gamma 2, microtubule-associated protein kinase, GTPase-activating protein, and phosphatidylinositol 3-kinase.
Pleiman CM; Clark MR; Gauen LK; Winitz S; Coggeshall KM; Johnson GL; Shaw AS; Cambier JC
Mol Cell Biol; 1993 Sep; 13(9):5877-87. PubMed ID: 8395016
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis of the ligand for the neu oncogenic receptor.
Yarden Y; Peles E
Biochemistry; 1991 Apr; 30(14):3543-50. PubMed ID: 1672825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
